December 29th 2023
Our top coverage from the CHEST Annual Meeting 2023 explored various topics, including strategies to prevent air pollutant exposure and keys to achieving equity in lung cancer screenings.
Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Age, Sex, Kidney Disease Predict Mortality for Patients Hospitalized With Respiratory Diseases
July 7th 2022A recent study found that older age, male sex, residence in a long-term care home, and chronic kidney disease were shared predictors of increased mortality for patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2.
Read More
Identifying Consistent Characteristics Among Patients With Refractory, Unexplained Chronic Cough
June 24th 2022Individuals with refractory or unexplained chronic cough had characteristics consistent of those with chronic cough in general, including cough duration, severity, and 24-hour frequency.
Read More
Dr Roxana Siles: QOL Improves Greatly From Effective Chronic Cough Treatment
June 14th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).
Watch
GlaxoSmithKline (GSK) aims to have its respiratory syncytial virus (RSV) vaccine reviewed later this year; Northwell Health and Kaiser Permanente among CEOs supporting gun legislation; Infants whose mothers had COVID-19 during their pregnancy had double the risk of delayed speech or motor skills.
Read More
Vaping Injuries Associated With Long-term Respiratory Problems, Study Finds
June 9th 2022A new study found that patients with e-cigarette or vaping–associated lung injury had a higher risk of developing respiratory disability, cognitive impairment, symptoms of depression, anxiety, and posttraumatic stress within 1 year of their injury.
Read More
Research Suggests COVID-19 Vaccines May Protect Against Pneumonia
June 2nd 2022Chest computed tomography scans demonstrated a lower frequency of pneumonia in fully vaccinated patients compared with unvaccinated patients, with a significantly lower frequency among patients who received the Pfizer vaccine.
Read More
Dr Roxana Siles: We Need to Address the Needs of Patients With Refractory/Unexplained Cough
May 22nd 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, discusses the important need for chronic cough therapies and what issues with current treatments should be addressed by next-generation medications.
Watch
High Proportions of Deaths Among Infants, Children Linked to RSV, Researchers Find
May 20th 2022Researchers also found that 95% of respiratory syncytial virus (RSV)-associated acute lower respiratory infection episodes and more than 97% of RSV-attributable deaths were among children in low– and middle-income countries.
Read More
Dr Roxana Siles: Blinded Trials Are Important When Evaluating Chronic Cough Treatment
May 6th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the placebo effect seen in clinical trials of chronic cough treatment.
Watch
NFID Board Members Explain Their Hopes for the Future of RSV Treatment, Prevention
April 28th 2022William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain what strategies they look forward to being implemented in the prevention and treatment of respiratory syncytial virus (RSV).
Watch
Dr Roxana Siles: Multispecialty Management of Chronic Cough Maximizes Patient Benefits
April 12th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the factors that contribute to necessitating multispecialty management of patients with chronic cough.
Watch
NFID Board Members Discuss Solutions to RSV-Related Disparities
April 2nd 2022William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.
Watch
Record High Pediatric Parainfluenza Virus Incidence in Finland
March 25th 2022Monthly parainfluenza virus incidence rates were nearly 6 times higher in September 2021 vs the second highest reported monthly incidence rates among children 4 years and younger in Finland in the last decade, following lifting of COVID-19–related restrictions.
Read More
NFID Board Members: We Need More Accessible, Less Expensive RSV Testing
March 19th 2022William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how COVID-19 testing developments have opened doors for developments in respiratory syncytial virus (RSV) testing.
Watch
Study Finds Better Outcomes When Patients Admitted With ARF Have Quick Inter-ICU Transfers
March 11th 2022A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.
Read More